| Richard G. Ghalie |
Richard G. Ghalie currently works at Viracta Subsidiary, Inc., as Director from 2015 and MEI Pharma, Inc., as Chief Medical Officer from 2021. Dr. Ghalie also formerly worked at Immunex Corp., as Senior Medical Director-Oncology Products from 1994 to 2001, Rush University Medical Center, as Medical Director-Bone Marrow Transplant Center, Poniard Pharmaceuticals, Inc., as VP-Clinical Research & Regulatory Affairs from 2001 to 2003, Ligand Pharmaceuticals, Inc., as VP-Medical Affairs & Professional Services from 2003 to 2007, Favrille, Inc., as Chief Medical Officer from 2007 to 2009, Novalar Pharmaceuticals, Inc., as Chief Medical Officer, HemaQuest Pharmaceuticals, Inc., as Chief Medical Officer, and Denovo Biopharma LLC, as Chief Medical Officer. Dr. Ghalie received his Masters Business Admin degree from the University of Washington, doctorate degree from St. Joseph's College, and graduate degree from Université Paris Diderot-Paris 7. |
| Eric Deng |
Eric Deng is currently working as the Vice President-Technical Operations at MEI Pharma, Inc. He holds a doctorate degree from The Ohio State University and an MBA from the University of Houston. |
| Jason Sausser |
Jason Sausser is currently the Vice President-Information Systems at MEI Pharma, Inc. He previously worked as the Head-Information Technology at Omniome, Inc. Sausser has a graduate degree from San Diego State University and an undergraduate degree from the University of Redlands. |
| Anne Frese |
Anne Frese is currently the Chief People Officer at MEI Pharma, Inc. Her former jobs include being the Vice President of Human Resources at Bellicum Pharmaceuticals, Inc. from 2015 to 2018, and the Vice President of Human Resources at Artiva Biotherapeutics, Inc. from 2019 to 2021. She also held the position of Chief Human Resources Officer at Vyripharm Enterprises LLC. Ms. Frese received her undergraduate degree from McGill University. |
| Justin J. File |
Justin J. File is currently the Chief Financial Officer & Secretary at MEI Pharma, Inc. Prior to his current position, he served as the Chief Financial Officer at Evofem, Inc. and Catalyst Global. He also held the position of Controller, Chief Financial & Accounting Officer at Sequenom, Inc. Mr. File completed his undergraduate degree at Central Washington University. |
| David M. Urso |
David M. Urso was the founder of Tioga Pharmaceuticals, Inc. (founded in 2005) where he held the title of COO, Director & General Counsel from 2013 to 2014. He is currently the President, Chief Executive Officer & Director at MEI Pharma, Inc. (since 2014). In his former positions, he worked as the Director-Corporate Development & Legal Affairs at DNA Sciences, Inc. from 2000 to 2002, and as an Attorney at Cooley Godward LLP from 1997 to 2000 and at Wilson Sonsini Goodrich & Rosati PC from 1995 to 1997. He also worked as a Scientist at GlaxoSmithKline LLC and Perelman School of Medicine. Mr. Urso received his undergraduate degree from The Reed Institute and his graduate degree from Harvard Law School. |
| Charles V. Baltic |
Charles V. Baltic is currently the Chairman at MEI Pharma, Inc., Chairman at AssayQuant Technologies, Inc., and Executive Vice President at SIDIS, Inc. He previously served as the Chief Executive Officer at Amyndas Pharmaceuticals LLC, Director-Life Science at Cowen & Co. (New York), Managing Director-Healthcare Investment Banking at Wachovia Securities LLC, Managing Director & Co-Head-Healthcare at Needham & Co. LLC, Managing Director at CRT Capital Group LLC, Director at MedVantage, Inc., Member at US Securities & Exchange Commission, Trustee at Washington Biotechnology & Biomedical Association, Founding Trustee at The Hope Funds for Cancer Research, and Chief Operations Officer at Sidis Corp. Mr. Baltic has an undergraduate and graduate degree from Georgetown University and an MBA from The Wharton School of the University of Pennsylvania. |
| Caroline Ruiz |
Caroline Ruiz is currently the Vice President-Clinical Operations at MEI Pharma, Inc. Her former job was as a Senior Director-Project Leadership at IQVIA Holdings, Inc. She completed her undergraduate degree at the University of California. |
